February 2025 FDA Recall Drug by Turbare Manufacturing
D-0248-2025 - Lack of Assurance of Sterility

This Class II drug recall was voluntarily initiated by Turbare Manufacturing on February 18, 2025 for the product Drug. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed Nationwide and the recall is currently completed.

Recall Number: D-0248-2025

Reason for Recall
Lack of Assurance of Sterility: due to a quality control process deviation
Initiated
02-18-2025
Reported
03-05-2025
Quantity
1,147 syringes

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Turbare Manufacturing
Nationwide in the USA
Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe, For Intravitreal Injection Only, Office Use Only - Not for Resale - Single Use, This drug product was repackaged by Turbare Manufacturing, 925 Jeanette Drive, Conway, AR 72032, NDC: 83556-0101-01.

Batch or Lot Expiration Information

Lot# s: 12122024@2 (BUD: 3/12/2025); 12192024@2 (BUD: 4/18/2025).